• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过聚合酶链反应对接受自体骨髓或外周血祖细胞移植患者的全血样本进行巨细胞病毒监测。

Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation.

作者信息

Hebart H, Schröder A, Löffler J, Klingebiel T, Martin H, Wassmann B, Gerneth F, Rabenau H, Jahn G, Kanz L, Müller C A, Einsele H

机构信息

Medizinische Universitätsklinik, Abteilung II, Kinderklinik, Institut für Medizinische Informationsverarbeitung, and Abteilung für Medizinische Virologie, Universität Tübingen, Germany.

出版信息

J Infect Dis. 1997 Jun;175(6):1490-3. doi: 10.1086/516484.

DOI:10.1086/516484
PMID:9180191
Abstract

Sensitive screening for cytomegalovirus (CMV) by polymerase chain reaction (PCR) following autologous bone marrow or peripheral blood progenitor cell transplantation has not been evaluated. In a three-center study, 98 autograft transplant recipients were prospectively screened for CMV infection by PCR and culture techniques. At a median of 20 days (range, 3-28) after transplantation, 21 (39.6%) of 53 CMV-seronegative patients were PCR positive for CMV, and at a median of 17 days (range, 7-84) after transplantation, 19 (42.2%) of 45 CMV-seropositive patients were PCR positive for CMV. Low-level DNAemia (1-10 fg CMV DNA/mL blood) occurred for 1 week in 31 patients but was never associated with CMV disease. Of 9 patients who presented with at least two consecutive positive PCR results, 1 developed CMV pneumonia. No patients died because of CMV disease. Screening for CMV infection by PCR had a negative predictive value of 100% (as also observed after allogeneic transplantation), but its positive predictive value was significantly lower.

摘要

自体骨髓或外周血祖细胞移植后通过聚合酶链反应(PCR)对巨细胞病毒(CMV)进行灵敏筛查尚未得到评估。在一项三中心研究中,对98名自体移植受者采用PCR和培养技术对CMV感染进行前瞻性筛查。在移植后中位时间20天(范围3 - 28天)时,53名CMV血清学阴性患者中有21名(39.6%)CMV的PCR检测呈阳性,在移植后中位时间17天(范围7 - 84天)时,45名CMV血清学阳性患者中有19名(42.2%)CMV的PCR检测呈阳性。31名患者出现低水平病毒血症(1 - 10 fg CMV DNA/毫升血液)持续1周,但从未与CMV疾病相关。在9名至少连续两次PCR结果呈阳性的患者中,1名发生了CMV肺炎。没有患者因CMV疾病死亡。通过PCR筛查CMV感染的阴性预测值为100%(同种异体移植后也观察到),但其阳性预测值显著更低。

相似文献

1
Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation.通过聚合酶链反应对接受自体骨髓或外周血祖细胞移植患者的全血样本进行巨细胞病毒监测。
J Infect Dis. 1997 Jun;175(6):1490-3. doi: 10.1086/516484.
2
Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.儿童异基因造血干细胞移植中巨细胞病毒(CMV)血症的监测:CMV感染和疾病的发生率及转归
Transpl Infect Dis. 2008 Feb;10(1):19-23. doi: 10.1111/j.1399-3062.2007.00242.x. Epub 2007 May 19.
3
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.一项前瞻性研究,比较血浆中巨细胞病毒(CMV)定量聚合酶链反应和pp65抗原血症检测在监测异基因干细胞移植患者中的作用。
BMC Infect Dis. 2006 Nov 21;6:167. doi: 10.1186/1471-2334-6-167.
4
Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.诊断巨细胞病毒血清学阳性肾移植受者的巨细胞病毒疾病:聚合酶链反应检测巨细胞病毒血症与巨细胞病毒pp65抗原血症检测的比较
Clin Transplant. 1997 Aug;11(4):286-93.
5
Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.巨细胞病毒感染的监测:骨髓移植患者全血PCR、血浆PCR、pp65抗原血症检测及病毒培养的比较
Bone Marrow Transplant. 1996 May;17(5):861-8.
6
Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients.实时聚合酶链反应检测造血干细胞移植患者的巨细胞病毒血症。
Adv Ther. 2013 Aug;30(8):784-91. doi: 10.1007/s12325-013-0049-9.
7
Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant.评估Murex巨细胞病毒DNA杂交捕获检测法(2.0版)在异基因干细胞移植受者巨细胞病毒感染早期诊断中的应用。
Bone Marrow Transplant. 2001 Jul;28(2):213-8. doi: 10.1038/sj.bmt.1703115.
8
CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.外周血干细胞和骨髓移植后通过 pp65 抗原和定量 PCR 进行巨细胞病毒监测。
Bone Marrow Transplant. 2001 Oct;28(8):765-8. doi: 10.1038/sj.bmt.1703227.
9
Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.骨髓移植受者外周血白细胞和血浆中的巨细胞病毒DNA。
Transplantation. 1995 Nov 15;60(9):961-5.
10
Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR.通过实时聚合酶链反应对骨髓移植受者的人巨细胞病毒DNA进行定量分析。
J Clin Microbiol. 2001 Dec;39(12):4362-9. doi: 10.1128/JCM.39.12.4362-4369.2001.

引用本文的文献

1
Clinical application value of metagenomic second-generation sequencing technology in hematologic diseases with and without transplantation.二代宏基因组测序技术在移植前后血液病中的临床应用价值。
Front Cell Infect Microbiol. 2023 Jun 16;13:1135460. doi: 10.3389/fcimb.2023.1135460. eCollection 2023.
2
Cytomegalovirus in Haematological Tumours.血液肿瘤中的巨细胞病毒。
Front Immunol. 2021 Oct 18;12:703256. doi: 10.3389/fimmu.2021.703256. eCollection 2021.
3
Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study.
骨髓瘤和淋巴瘤患者自体干细胞移植后巨细胞病毒再激活:一项单中心研究。
World J Transplant. 2015 Sep 24;5(3):129-36. doi: 10.5500/wjt.v5.i3.129.
4
Cytomegalovirus Reactivation in Adult Recipients of Autologous Stem Cell Transplantation: a Single Center Experience.自体干细胞移植成年受者中的巨细胞病毒再激活:单中心经验
Mediterr J Hematol Infect Dis. 2015 Aug 24;7(1):e2015049. doi: 10.4084/MJHID.2015.049. eCollection 2015.
5
A cross-Canada survey of cytomegalovirus prevention and treatment practices in bone marrow transplant recipients.一项关于加拿大骨髓移植受者巨细胞病毒预防和治疗实践的全国性调查。
Can J Infect Dis. 1999 Nov;10(6):410-4. doi: 10.1155/1999/480541.
6
Cytomegalovirus in hematopoietic stem cell transplant recipients.造血干细胞移植受者巨细胞病毒感染。
Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69. doi: 10.1016/j.hoc.2010.11.011.
7
Comparison of DNA amplification, mRNA amplification, and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplant recipients.用于检测骨髓移植受者巨细胞病毒的DNA扩增、mRNA扩增及DNA杂交技术的比较
J Clin Microbiol. 2003 Nov;41(11):5159-66. doi: 10.1128/JCM.41.11.5159-5166.2003.
8
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.骨髓移植受者巨细胞病毒监测的分子方法
J Clin Microbiol. 2002 Nov;40(11):4203-6. doi: 10.1128/JCM.40.11.4203-4206.2002.
9
Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients.基于定量PCR的病毒载量分析对小儿实体器官移植患者八种人类疱疹病毒的预测价值。
J Mol Diagn. 2000 Nov;2(4):191-201. doi: 10.1016/S1525-1578(10)60637-X.
10
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.实体器官或干细胞移植后巨细胞病毒感染的管理。当前指南与未来展望。
Drugs. 1998 Jan;55(1):59-72. doi: 10.2165/00003495-199855010-00005.